Helvet Health wins bluebird bio EU Agency of Record gene replacement therapy in europe

Helvet Health Agency was awarded earlier in 2017 European Agency of Record for bluebird bio, supporting the Global marketing team both in thalassemia and cALD, two severe genetic diseases.

Helvet Health is working with bluebird bio to prepare European physicians and patients for what will certainly be a gene therapy revolution!

How we can help you?